Pregnancy in women with Alport syndrome

Int Urol Nephrol. 2013 Aug;45(4):1223-7. doi: 10.1007/s11255-012-0154-8. Epub 2012 Mar 15.

Abstract

Background: Little is known about pregnancy in women with Alport syndrome (AS), as only four cases have been reported in the literature. We herein describe the course of pregnancy in two sisters with overt forms of AS.

Cases: Both women were diagnosed as having autosomal recessive AS. Before pregnancy, their renal function and their blood pressure were normal, and proteinuria values were below 2 g/24 h. Both patients faced a progressive and remarkable increase in proteinuria during pregnancy, with subsequent hypoproteinemia. The clinical condition worsened, particularly in the first case, who was managed with some success with a combination of diuretics. She delivered at 32 weeks of pregnancy. The second patient was less challenging and she delivered at 36 weeks. Proteinuria returned to pre-pregnancy levels in both cases, after delivery.

Conclusion: Management of pregnant women with overt AS is challenging and worsening of renal disease has to be expected. The use of diuretic therapy may be of benefit.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cesarean Section
  • Female
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Kidney Function Tests
  • Nephritis, Hereditary / complications*
  • Nephritis, Hereditary / diagnosis
  • Nephrotic Syndrome / drug therapy*
  • Nephrotic Syndrome / etiology
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Pregnancy Complications / etiology*
  • Pregnancy Complications / physiopathology
  • Pregnancy Outcome*
  • Pregnancy, High-Risk*
  • Prenatal Care / methods
  • Proteinuria / drug therapy
  • Proteinuria / etiology
  • Risk Assessment
  • Siblings
  • Spironolactone / therapeutic use
  • Young Adult

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Spironolactone